Ethylene Glycol

Ethylene Glycol

SCHEMBL5342979

CC(COC(=O)C(C)O)OC(=O)C(C)O.OCCO

nearest known ligand 0.32

Full drug profile on Sugi Atlas →

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.32
PRKCA P17252 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1517819 0.94 TSHR (0.35) TSHR
SCHEMBL537244 0.86 TDP1 (0.33) TSHR
SCHEMBL31509395 0.86 TDP1 (0.33) TSHR
Ethylene Glycol SCHEMBL18096457 0.79
SCHEMBL24414497 0.78 FAAH (0.37) TSHR
SCHEMBL24414473 0.78 FAAH (0.37) TSHR
SCHEMBL24414503 0.78 FAAH (0.37) TSHR
SCHEMBL6440364 0.78 MEN1 (0.33) TSHR
SCHEMBL24414478 0.78 FAAH (0.37) TSHR
SCHEMBL24414491 0.78 FAAH (0.37) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160194455-A1 Silicone Elastomer Gels and Related Hydrosilylation Processes ALZO INT INC (US) 2016-07-07 US claimed
US-20150274972-A1 ENHANCED WATER AND TRANSFER RESISTANT FILM FORMING ALZO INTERNATIONAL, INC. (US) 2015-10-01 US claimed
EP-2906614-A1 ENHANCED WATER AND TRANSFER RESISTANT FILM FORMING Alzo International, Inc. (US) 2015-08-19 EP claimed
WO-2015048228-A2 IMPROVED SILICONE ELASTOMER GELS AND RELATED HYDROSILYLATION PROCESSES ALZO INTERNATIONAL, INC. (US) 2015-04-02 WO claimed
CN-103432091-A Improved-performance tablet and preparation method thereof ZHONG SHUGUANG 2013-12-11 CN claimed
US-20260090970-A1 POLYTERPENE FILM FORMER FOR COSMETIC APPLICATIONS MOMENTIVE PERFORMANCE MAT INC (US) 2026-04-02 US disclosed
US-20250354008-A1 BIO-DERIVED GREEN PARTICLE COMPOSITIONS AND METHODS THEREOF MOMENTIVE PERFORMANCE MAT INC (US) 2025-11-20 US disclosed
US-20250213460-A1 NATURAL DERIVED FILM FORMER FOR COSMETIC APPLICATIONS MOMENTIVE PERFORMANCE MATERIALS INC. 2025-07-03 US disclosed
WO-2025132800-A1 PERSONAL CARE COMPOSITIONS COMPRISING LACTIC ACID ESTERS BASF SE (DE) 2025-06-26 WO disclosed
CN-115670967-A Lipophilic starch, method for producing the same, and cosmetic composition containing the same 台钜生技股份有限公司 2023-02-03 CN disclosed
EP-4098645-A1 PROCESS FOR MAKING BIOBASED PROPYLENE GLYCOL FROM LACTIC ACID ESTERS Archer Daniels Midland Company (US) 2022-12-07 EP disclosed
CN-111607461-B Perfume containing secondary metabolite of solanaceae plant, preparation method thereof and perfume product 深圳昱朋科技有限公司 2021-07-09 CN disclosed
EP-0831774-B1 ORAL DOSAGE AND METHOD FOR TREATING PAINFUL CONDITIONS OF THE ORAL CAVITY ALZA CORP (US) 2001-07-11 EP disclosed
US-5897878-A ORALLY ADMINISTERING DELIVERY SYSTEM IN WHICH FLUID IMBIBITION CAUSES HYDROPHILIC POLYMER TO AGGREGATE IN SITU IN PRESENCE OF POLYHYDROXY COMPOUND AND CAUSES PUSH LAYER TO ABSORB FLUID AND DELIVER AGGREGATES CONTAINING STEROID ALZA CORPORATION (US) 1999-04-27 US disclosed
US-5830501-A DRUG DELIVERY TO MUCOSAL TISSUE, SEMIPERMEABLE WALL, PRECIPITATION ALZA CORPORATION (US) 1998-11-03 US disclosed
US-5713852-A Oral dosage and method for treating painful conditions of the oral cavity ALZA CORPORATION (US) 1998-02-03 US disclosed
US-5348746-A Method for administering drug ALZA CORPORATION (US) 1994-09-20 US disclosed
US-5266332-A Oral administering of drugs with semipermeable walls and multicompartment polymer with electrolyte ALZA CORPORATION (US) 1993-11-30 US disclosed
US-5254349-A Flocculating drug and hydrophilic polymer in dosage form ALZA CORPORATION (US) 1993-10-19 US disclosed
US-5200195-A Reducing stickiness of a dosage for to biological tissue in fluid environment of use ALZA CORPORATION (US) 1993-04-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250213460-A1 NATURAL DERIVED FILM FORMER FOR COSMETIC APPLICATIONS DSG1, CUTA, CDH1 TSHR 4143/4885PRKCA 3446/4885
US-20150274972-A1 ENHANCED WATER AND TRANSFER RESISTANT FILM FORMING CUTA, TRRAP, LCP1 TSHR 4184/4885PRKCA 1739/4885
US-20260090970-A1 POLYTERPENE FILM FORMER FOR COSMETIC APPLICATIONS CUTA, LIPE, TNK1 TSHR 1665/4885PRKCA 1357/4885
US-20160194455-A1 Silicone Elastomer Gels and Related Hydrosilylation Processes ITCH, MMS19, STS TSHR 3868/4885PRKCA 3648/4885
US-20250354008-A1 BIO-DERIVED GREEN PARTICLE COMPOSITIONS AND METHODS THEREOF ALG1, PARG, RECQL TSHR 4498/4885PRKCA 560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.